{
  "paper_id": "d672ce4063b2033261865d54cc7db91b9186beee",
  "metadata": {
    "title": "Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-kB Signaling Pathway in Rodents",
    "coda_data_split": "test",
    "coda_paper_id": 698,
    "coda_has_expert_labels": false,
    "subset": "comm_use_subset"
  },
  "abstract": [
    {
      "original_text": "Background and Purpose: Successful drug treatment for sepsis-related acute lung injury (ALI) remains a major clinical problem. This study was designed to assess the beneficial effects of post-treatment of oroxylin A (OroA), a flavonoid, in ameliorating lipopolysaccharides (LPS)-induced lung inflammation and fatality.",
      "sentences": [
        [
          {
            "segment_text": "Background and Purpose : Successful drug treatment for sepsis-related acute lung injury ( ALI ) remains a major clinical problem .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "This study was designed to assess the beneficial effects of post-treatment of oroxylin A ( OroA ) ,",
            "crowd_label": "purpose"
          },
          {
            "segment_text": "a flavonoid , in ameliorating lipopolysaccharides ( LPS ) - induced lung inflammation and fatality .",
            "crowd_label": "purpose"
          }
        ]
      ]
    },
    {
      "original_text": "Experimental Approach: Rats were injected with LPS (10 mg/kg, iv) to induce ALI, and OroA was given (15 mg/kg, iv) 1 hr or 6 hrs after LPS challenge. Twenty four hrs after LPS challenge, biochemical changes in the blood and lung tissues, and morphological/histological alterations in the lung associated with inflammation and injury were examined. Therapeutic effect of OroA was assessed by measuring the survival rate in endotoxemic mice.",
      "sentences": [
        [
          {
            "segment_text": "Experimental Approach : Rats were injected with LPS ( 10 mg/kg , iv ) to induce ALI ,",
            "crowd_label": "method"
          },
          {
            "segment_text": "and OroA was given ( 15 mg/kg , iv ) 1 hr or 6 hrs after LPS challenge .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Twenty four hrs after LPS challenge ,",
            "crowd_label": "method"
          },
          {
            "segment_text": "biochemical changes in the blood and lung tissues ,",
            "crowd_label": "method"
          },
          {
            "segment_text": "and morphological/histological alterations in the lung associated with inflammation and injury were examined .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Therapeutic effect of OroA was assessed by measuring the survival rate in endotoxemic mice .",
            "crowd_label": "method"
          }
        ]
      ]
    },
    {
      "original_text": "Key Results: LPS (10 mg/kg, iv) significantly altered WBC counts, elevated plasma tumor necrosis factor (TNF)-a and nitric oxide (NO), increased pulmonary edema, thickened alveolar septa, and decreased survival rate. These changes were ameliorated by OroA (15 mg/kg, iv) administered 1 hr or 6 hrs after LPS challenge. This post-treatment also significantly attenuated LPS-induced activation of nuclear factor-kB (NF-kB) and the release of high mobility group box 1 (HMGB1) in lung tissues. Furthermore, post-treatment with OroA (60 mg/kg, ip) administered 1 hr or 6 hrs after LPS challenge in mice significantly increased survival rate.",
      "sentences": [
        [
          {
            "segment_text": "Key Results : LPS ( 10 mg/kg , iv ) significantly altered WBC counts ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "elevated plasma tumor necrosis factor ( TNF ) - a and nitric oxide ( NO ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "increased pulmonary edema , thickened alveolar septa , and decreased survival rate .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "These changes were ameliorated by OroA ( 15 mg/kg , iv ) administered 1 hr or 6 hrs after LPS challenge .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "This post-treatment also significantly attenuated LPS-induced activation of nuclear factor-kB ( NF-kB ) and the release of high mobility group box 1 ( HMGB1 ) in lung tissues .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Furthermore , post-treatment with OroA ( 60 mg/kg , ip ) administered 1 hr or 6 hrs after LPS challenge in mice significantly increased survival rate .",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "Conclusion and Implication: OroA administered after induction of ALI by LPS significantly prevent and revere lung tissues injuries with increased survival rate. Positive post-treatment effects of OroA suggest that OroA is a potentially useful candidate for managing lung inflammation in LPS-induced endotoxemia and septic shock.",
      "sentences": [
        [
          {
            "segment_text": "Conclusion and Implication : OroA administered after induction of ALI by LPS significantly prevent and revere lung tissues injuries with increased survival rate .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Positive post-treatment effects of OroA suggest that OroA is a potentially useful candidate for managing lung inflammation in LPS-induced endotoxemia and septic shock .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "4",
    "sentence_num": "11",
    "segment_num": "17",
    "token_num": "308"
  }
}